Ono Pharmaceutical
4528.TPharmaceutical
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥458.9bn | ¥451.8bn | ¥498.8bn | ¥441.2bn | ¥357.0bn | ¥305.2bn |
| Operating income | ¥103.7bn | ¥114.7bn | ¥187.9bn | ¥152.0bn | ¥119.9bn | ¥84.9bn |
| Ordinary income | ¥101.4bn | ¥112.3bn | ¥188.0bn | ¥150.8bn | ¥121.1bn | ¥86.8bn |
| Total assets | ¥1.05T | ¥1.03T | ¥847.3bn | ¥804.6bn | ¥661.9bn | ¥669.6bn |
| Net assets / equity | ¥844.8bn | ¥797.6bn | ¥750.2bn | ¥685.6bn | ¥599.2bn | ¥574.6bn |
| EPS (basic) | ¥169.72 | ¥218.02 | ¥318.51 | ¥239.96 | ¥190.51 | ¥154.1 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 15
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | AnnualAmended | 212 figures · EDINET |
| 2025-04-01 → 2026-03-31 | Annual | 212 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 82 figures · EDINET |
| 2024-04-01 → 2025-03-31 | AnnualAmended | 212 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 212 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 82 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 212 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 108 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 108 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 212 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 108 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 108 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 212 figures · EDINET |
21 more reports are still being processed.